|
Dr. McEver is a co-founder of Selexys, Vice President, Chief Medical Officer and serves on the Board. Dr. McEver is a Member and Program Chair of the Cardiovascular Biology Research Program at the Oklahoma Medical Research Foundation. Dr. McEver is a hematologist and distinguished expert in the field of vascular biology. He discovered P-selectin and developed the antibodies being advanced by the company. He is an inventor on the patents licensed by Selexys. As CMO he is responsible for overseeing the development of our disease target strategy and clinical trial plans. | 